Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Farallon Capital Discloses Stake in Sky Solar Holdings Ltd (ADR) (SKYS); See Fund’s Other Top New Picks

Page 1 of 2

Farallon Capital, a hedge fund founded by Thomas Steyer, has recently disclosed the initiation of a passive stake in Sky Solar Holdings Ltd (ADR) (NASDAQ:SKYS) according to a schedule 13G  form filed with the SEC. The fund now owns 30.0 million  shares of the independent power producer (IPP) that develops, owns and operates solar parks around the world, through its affiliates. The stake constitutes 7.7% of Sky Solar’s outstanding common stock.


Sky Solar Holdings Ltd (ADR) (NASDAQ:SKYS) is up by about 50% since its initial public offering in mid November last year. The $585.04 million company has also announced its plans to enter the Chinese solar market and is evaluating acquisition targets to that end.

Steyer had an illustrious career before he went on to set up Farallon Capital in 1986. He had worked both at Goldman Sachs at its risk arbitrage department, and also at Morgan Stanley in the mergers and acquisition division. Steyer stepped down from his post in Farallon in 2012 to pursue advocacy for alternative energy. As of the end of December last year, the value of the fund’s equity portfolio standsat $7.33 billion. Two significant sectors forming major chunks of the fund’s portfolio value were healthcare comprising 28% of the holdings and consumer discretionary constituting 30% of the portfolio value. Farallon added 30 new positions during the fourth quarter. The most notable of these in terms of value were long stakes in Baker Hughes Incorporated (NYSE:BHI), KLX Inc (NASDAQ:KLXI)and B/E Aerospace Inc (NASDAQ:BEAV). The fund also added Cubist Pharmaceuticals Inc (NASDAQ:CBST) and Rockwood Holdings, Inc. (NYSE:ROC) to its equity portfolio during the same period, but the companies have been sold since then.

While it is a good idea to follow the activism in the finance industry in order to invest alongside renowned activist investors as they create higher shareholder value by streamlining the companies, it can be taxing to keep track of their moves all the time. Moreover, even the best activists are not always successful. We have however formulated a portfolio strategy that can help a retail investor in outperforming the market. The strategy is based on 15 most popular small cap companies among over 700 hedge funds that we track, and we have been sharing these stock picks in our newsletters since 2012. Our strategy beat the S&P 500 ETF (SPY) by a staggering 79.4 percentage points since August 2012 through March 2015 and returned 132% during that period.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!